Identify undiagnosed patients with kidney disease and track their care to improve health outcomes and avoid large, unpredictable medical bills.
Minimize the cost of care by knowing which members are high-risk and driving early intervention.
Succeed in this shifting space by deploying precisely-targeted care delivery to the patients who need it most.
"We see the partnership between Rogosin and pulseData as critical to our future. We believe the current CKD project is the beginning of many collaborative projects to come and we look forward to the continued growth and success of our relationship."
— Dr. Jeffrey Silberzweig, Chief Medical Officer of The Rogosin Institute
We partner closely with your providers to reduce the burden of chronic disease across your population by letting them know exactly who is at risk of acute events and which of their care workflows are working.
COVID-19 has affected the lives of both the patients and the practice of nephrology. Despite the disruptive challenges created from being at the epicenter of COVID-19 (New York, NY), The Rogosin Institute multidisciplinary care team has been continuing to provide top-notch quality care powered by the pulseData intelligence platform
Stimulated by recent events there has been a very active debate among physicians about the role of race in medicine, we took a look at whether using race in the eGFR equation was useful in predicting renal failure events.
Last week the The Centers for Medicare & Medicaid Services Innovation (CMMI) Center announced that it would be pushing ahead with the new Kidney Care Choices (KCC) payment models, with launch date of April 1, 2021. pulseData has been developing new tools to help practices deliver value based care and succeed under these new models.
